Becker's Healthcare June 10, 2025
Texas is set to launch one of the largest public investments in psychedelics research, The Washington Post reported June 9.
The state will provide up to $50 million to jump-start clinical trials of ibogaine, a psychedelic that could be a treatment for mental health and addiction conditions. The funding was approved by Texas lawmakers, and Gov. Greg Abbott is expected to sign it into law, The Post reported.
Here are three things to know:
- No U.S. clinical trials have been completed on ibogaine, according to The Post. The National Institute on Drug Abuse has awarded companies more than $14 million for...
Today's Sponsors
Today's Sponsor